High Quality Stock Setups, Weekly Stock Bull Finder

Weekly Stock Bull Finder

High Quality Stock Setups

Finding high potential stock setups on quality companies

Thematic (Sector/Industry)

<ul><li>When considering future investment opportunities, the renewable energy transition continues to be an exciting space to investors given its enormous potential total addressable market coupled with climate change legislation that is acting as a tailwind in virtually every G-20 country.</li><li>Almost every month, there continues to be a steady drumbeat of new rules issued locally and across the globe which results in faster timelines to transition to battery storage and other clean energy as well as tighter restrictions to ultimately phase out traditional gas powered transportation and coal power.</li><li>For example, while California has already passed rules requiring all new cars, pickup trucks and SUVs sold to be electric or hydrogen by 2035, California approved rules last week which will require all new medium heavy-duty truck and bus sales sold in the state in 2036 to be zero-emission</li></ul>

When considering future investment opportunities, the renewable energy transition continues to be an exciting space to investors given its enormous potential total addressable market coupled with climate change legislation that is acting as a tailwind in virtually every G-20 country.Almost every month, there continues to be a steady drumbeat of new rules issued locally and across the globe which results in faster timelines to transition to battery storage and other clean energy as well as tighter restrictions to ultimately phase out traditional gas powered transportation and coal power.For example, while California has already passed rules requiring all new cars, pickup trucks and SUVs sold to be electric or hydrogen by 2035, California approved rules last week which will require all new medium heavy-duty truck and bus sales sold in the state in 2036 to be zero-emission

<ul><li>According to BeSpoke investment firm research, the top 10% of the most heavily shorted stocks are up an average of 36.3% so far this year.</li><li>This includes troubled retailer Bed Bath &amp; Beyond (BBBY) whose shares surged by more than 18% Thursday, a day after they missed a Feb. 1 interest payment and warned that it might file for bankruptcy within weeks.</li><li>Other stocks like online car dealer Carvana and any company which has anything remotely associated with artificial intelligence (AI) have seen similar spikes.</li></ul>

According to BeSpoke investment firm research, the top 10% of the most heavily shorted stocks are up an average of 36.3% so far this year.This includes troubled retailer Bed Bath &amp; Beyond (BBBY) whose shares surged by more than 18% Thursday, a day after they missed a Feb. 1 interest payment and warned that it might file for bankruptcy within weeks.Other stocks like online car dealer Carvana and any company which has anything remotely associated with artificial intelligence (AI) have seen similar spikes.

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Inspire Medical Systems Inc / Equity Bottom-Up

<ul><li>Inspire Medical Systems released its financial results for the first quarter of 2025.</li><li>The company's revenue reached $201.3 million, marking a 23% increase compared to the same quarter the previous year.</li><li>Net income for Q1 was $3 million with a diluted net income of $0.10 per share, showing a notable improvement from the net loss of $10 million and a net loss of $0.34 per share in Q1 2024.</li></ul>

Inspire Medical Systems released its financial results for the first quarter of 2025.The company's revenue reached $201.3 million, marking a 23% increase compared to the same quarter the previous year.Net income for Q1 was $3 million with a diluted net income of $0.10 per share, showing a notable improvement from the net loss of $10 million and a net loss of $0.34 per share in Q1 2024.

Inspire Medical Systems Ramps Manufacturing Muscle—Will The Inspire V Rollout Be A Game Changer?

<ul><li>Inspire Medical Systems demonstrated a strong performance in fiscal year 2024 with notable achievements and financial results.</li><li>The company showed significant progress in both the U.S. and international markets, indicating a positive trajectory for its operations and market presence.</li><li>Revenue for 2024 reached $802.8 million, marking a 28% increase from the previous year.</li></ul>

Inspire Medical Systems demonstrated a strong performance in fiscal year 2024 with notable achievements and financial results.The company showed significant progress in both the U.S. and international markets, indicating a positive trajectory for its operations and market presence.Revenue for 2024 reached $802.8 million, marking a 28% increase from the previous year.

Inspire Medical Systems: Will The Expansion of Inspira V Be A Game Changer?

<ul><li>Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in profitability.</li><li>The company's revenue for the third quarter was $203.2 million, up 33% compared to the same period in 2023.</li><li>This growth was predominantly driven by the increased adoption of Inspire therapy, reflected in the expansion into 66 new implanting centers and growth in 13 new U.S. sales territories.</li></ul>

Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in profitability.The company's revenue for the third quarter was $203.2 million, up 33% compared to the same period in 2023.This growth was predominantly driven by the increased adoption of Inspire therapy, reflected in the expansion into 66 new implanting centers and growth in 13 new U.S. sales territories.

Inspire Medical Systems: Is The New Inspire V System A Game Changer? - Major Drivers

United States

Inspire Medical Systems, Inc. operates as a medical technology company. The Company develops implantable neurostimulation systems to treat obstructive sleep apnea. Inspire Medical Systems operates in the the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Inspire Medical Systems Inc (INSP US)

Weekly Stock Bullfinder - Week of 5/1

When considering future investment opportunities, the renewable energy transition continues to be an exciting space to investors given its enormous...

Weekly Stock Bull Finder

Weekly Stock Bullfinder - Week of 2/6

According to BeSpoke investment firm research, the top 10% of the most heavily shorted stocks are up an average of 36.3% so far this year.

Weekly Stock Bull Finder

Inspire Medical Systems Ramps Manufacturing Muscle—Will The Inspire V Rollout Be A Game Changer?

Inspire Medical Systems released its financial results for the first quarter of 2025. The company's revenue reached $201.3 million, marking a 23%...

Baptista Research

Inspire Medical Systems: Will The Expansion of Inspira V Be A Game Changer?

Inspire Medical Systems demonstrated a strong performance in fiscal year 2024 with notable achievements and financial results. The company showed...

Baptista Research

Inspire Medical Systems: Is The New Inspire V System A Game Changer? - Major Drivers

Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)